Normal view MARC view ISBD view

Spectrophotometric determination of nizatidine and ranitidine through charge transfer complex formation. [electronic resource]

By:

Walash, M

Contributor(s):

Producer: 20050218Description: 720-6 p. digitalISSN:

0253-6269

Subject(s):

Online resources:

Available from publisher's website

In: Archives of pharmacal research vol. 27

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Farnesoid X receptor: a new player in glucose metabolism?
by Cariou, Bertrand
2 Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
by Duran-Sandoval, Daniel
3 [Pharmacology of PPARalpha, PPARgamma and dual PPARalpha/gamma agonists in clinical development].
by Duran-Sandoval, Daniel
4 The gene encoding acyl-CoA-binding protein is subject to metabolic regulation by both sterol regulatory element-binding protein and peroxisome proliferator-activated receptor alpha in hepatocytes.
by Sandberg, Maria B
5 Pharmacokinetics of low molecular weight phenolic compounds in gerbil plasma after the consumption of calafate berry (Berberis microphylla) extract.
by Bustamante, Luis
6 Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme.
by Barbier, Olivier
7 Evaluation of microextraction by packed sorbent, liquid-liquid microextraction and derivatization pretreatment of diet-derived phenolic acids in plasma by gas chromatography with triple quadrupole mass spectrometry.
by Bustamante, Luis
8 Glucose regulates the expression of the farnesoid X receptor in liver.
by Duran-Sandoval, Daniel
9 Sequential estrogen-progestin replacement therapy in healthy postmenopausal women: effects on cholesterol efflux capacity and key proteins regulating high-density lipoprotein levels.
by Ulloa, Natalia
10 Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
by Claudel, Thierry
11 FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity.
by Barbier, Olivier
12 High LDL levels are associated with increased lipoprotein-associated phospholipase A(2) activity on nitric oxide synthesis and reactive oxygen species formation in human endothelial cells.
by Searle, Andrea
13 Transient impairment of the adaptive response to fasting in FXR-deficient mice.
by Cariou, Bertrand
14 The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition.
by Duran-Sandoval, Daniel
15 Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
by Nowak, Maxime
16 The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.
by Cariou, Bertrand
17 Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia.
by Caron, Sandrine